These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
43 results:

  • 1. Use of 3D-CT-derived psoas major muscle volume in defining sarcopenia in colorectal cancer.
    Takahashi M; Sakamoto K; Kogure Y; Nojiri S; Tsuchiya Y; Honjo K; Kawai M; Ishiyama S; Sugimoto K; Nagakari K; Tomiki Y
    BMC Cancer; 2024 Jun; 24(1):741. PubMed ID: 38890682
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes.
    Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H
    Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction.
    Pastorino GA; Sheraj I; Huebner K; Ferrero G; Kunze P; Hartmann A; Hampel C; Husnugil HH; Maiuthed A; Gebhart F; Schlattmann F; Gulec Taskiran AE; Oral G; Palmisano R; Pardini B; Naccarati A; Erlenbach-Wuensch K; Banerjee S; Schneider-Stock R
    J Pathol; 2024 Mar; 262(3):347-361. PubMed ID: 38235615
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Unraveling a novel hippo-associated immunological prognostic signature: The contribution of serpine1 in facilitating colorectal cancer progression via the notch signaling pathway.
    Su X; Wang X; Lai J; Mao S; Li H
    Genomics; 2024 Mar; 116(2):110794. PubMed ID: 38224823
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer.
    Yang J; Zhao Y; Yuan R; Wang Y; Wang S; Chang Z; Zhao W
    Eur J Med Res; 2023 Nov; 28(1):533. PubMed ID: 37986009
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
    Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
    Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Machine Learning Predicts the Oxidative Stress Subtypes Provide an Innovative Insight into colorectal cancer.
    Zhong H; Yang L; Zeng Q; Chen W; Zhao H; Wu L; Qin L; Yu QQ
    Oxid Med Cell Longev; 2023; 2023():1737501. PubMed ID: 37122535
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Seven bacterial response-related genes are biomarkers for colon cancer.
    Xiong Z; Li W; Luo X; Lin Y; Huang W; Zhang S
    BMC Bioinformatics; 2023 Mar; 24(1):103. PubMed ID: 36941538
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes.
    Zhou R; Gao Z; Ju Y
    BMC Bioinformatics; 2022 Oct; 23(1):418. PubMed ID: 36221049
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Circ-GALNT16 restrains colorectal cancer progression by enhancing the SUMOylation of hnRNPK.
    Peng C; Tan Y; Yang P; Jin K; Zhang C; Peng W; Wang L; Zhou J; Chen R; Wang T; Jin C; Ji J; Feng Y; Tang J; Sun Y
    J Exp Clin Cancer Res; 2021 Aug; 40(1):272. PubMed ID: 34452628
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for pai-1.
    Durlanik S; Fundel-Clemens K; Viollet C; Huber HJ; Lenter M; Kitt K; Pflanz S
    Sci Rep; 2021 Jul; 11(1):14849. PubMed ID: 34290311
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. serpine1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target.
    Wang S; Pang L; Liu Z; Meng X
    BMC Cancer; 2021 Jul; 21(1):767. PubMed ID: 34215248
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets.
    Li R; Li Y; Liang X; Yang L; Su M; Lai KP
    Brief Bioinform; 2021 Mar; 22(2):1279-1290. PubMed ID: 33169132
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis.
    Liu Y; Li C; Dong L; Chen X; Fan R
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32936304
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. pai1 is a Marker of Bad prognosis in Rectal cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.
    Muñoz-Galván S; Rivero M; Peinado-Serrano J; Martinez-Pérez J; Fernández-Fernández MC; Ortiz MJ; García-Heredia JM; Carnero A
    Cells; 2020 Apr; 9(5):. PubMed ID: 32344898
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Stromal coexpression of uPA/pai-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
    Singer CF; Filipits M; Jahn SW; Abete L; Jakesz R; Greil R; Bauernhofer T; Kwasny W; Seifert M; Fitzal F; Kastner M; Schmitt M; Moinfar F; Gnant M
    Breast; 2019 Aug; 46():101-107. PubMed ID: 31132475
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the prognosis of Human Colon Adenocarcinoma.
    Wang WJ; Li HT; Yu JP; Han XP; Xu ZP; Li YM; Jiao ZY; Liu HB
    J Surg Res; 2019 Mar; 235():22-33. PubMed ID: 30691798
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
    Liang Y; Zhang C; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis.
    Chen H; Peng H; Liu W; Sun Y; Su N; Tang W; Zhang X; Wang J; Cui L; Hu P; Liu S
    Surgery; 2015 Dec; 158(6):1704-13. PubMed ID: 26275833
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer.
    Divella R; Daniele A; Abbate I; Bellizzi A; Savino E; Simone G; Giannone G; Giuliani F; Fazio V; Gadaleta-Caldarola G; Gadaleta CD; Lolli I; Sabbà C; Mazzocca A
    Cancer Causes Control; 2014 Nov; 25(11):1531-41. PubMed ID: 25135616
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.